"Bridged-Ring Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Cyclic hydrocarbons that contain multiple rings which share one or more bridgehead connections.
| Descriptor ID |
D001952
|
| MeSH Number(s) |
D02.455.426.100 D04.075
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bridged-Ring Compounds".
Below are MeSH descriptors whose meaning is more specific than "Bridged-Ring Compounds".
This graph shows the total number of publications written about "Bridged-Ring Compounds" by people in this website by year, and whether "Bridged-Ring Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2014 | 0 | 1 | 1 |
| 2017 | 1 | 3 | 4 |
| 2018 | 3 | 2 | 5 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Bridged-Ring Compounds" by people in Profiles.
-
Supramolecular Mechanism of Viral Envelope Disruption by Molecular Tweezers. J Am Chem Soc. 2020 10 07; 142(40):17024-17038.
-
Multicenter, single arm, phase II trial on the efficacy of ortataxel in recurrent glioblastoma. J Neurooncol. 2019 May; 142(3):455-462.
-
Pacritinib in Patients With Myelofibrosis. JAMA Oncol. 2018 12 01; 4(12):1786-1787.
-
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer. PLoS Biol. 2018 07; 16(7):e2005869.
-
Pacritinib to treat myelofibrosis patients with thrombocytopenia. Expert Rev Hematol. 2018 09; 11(9):707-714.
-
Outcomes of patients with myelofibrosis treated with compassionate use pacritinib: a sponsor-independent international study. Ann Hematol. 2018 Aug; 97(8):1369-1374.
-
The molecular tweezer CLR01 inhibits Ebola and Zika virus infection. Antiviral Res. 2018 04; 152:26-35.
-
Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer. J Clin Oncol. 2017 Aug 10; 35(23):2600-2603.
-
Anthracyclines in Early Breast Cancer: The ABC Trials-USOR 06-090, NSABP B-46-I/USOR 07132, and NSABP B-49 (NRG Oncology). J Clin Oncol. 2017 Aug 10; 35(23):2647-2655.
-
Concurrent versus sequential adjuvant chemo-endocrine therapy in hormone-receptor positive early stage breast cancer patients: a systematic review and meta-analysis. Breast. 2017 Jun; 33:104-108.